{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T03:55:16Z","timestamp":1790567716707,"version":"4.1.0"},"reference-count":14,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"abstract":"<jats:p>\n                    Commentary on: Long Title: Phase 3, randomised, placebo\u2010controlled trial of Voxelotor for the resolution of leg ulcers in sickle cell disease: RESOLVE. Br J Haematol (Online ahead of print). doi:\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/doi.org\/10.1111\/bjh.70856\">10.1111\/bjh.70856<\/jats:ext-link>\n                    .\n                  <\/jats:p>","DOI":"10.1111\/bjh.70857","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T03:06:53Z","timestamp":1790564813000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["<scp>RESOLVE<\/scp>\n                    to do better"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6526-9674","authenticated-orcid":false,"given":"Jane A.","family":"Little","sequence":"first","affiliation":[{"name":"Adult Sickle Cell Disease Clinic at University of North Carolina\u2010Chapel Hill  Chapel Hill North Carolina USA"},{"name":"UNC Blood Research Center  Chapel Hill North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,27]]},"reference":[{"key":"e_1_2_4_2_1","article-title":"RESOLVE","author":"Ogutu B","year":"2026","journal-title":"Br J Haematol"},{"issue":"3","key":"e_1_2_4_3_1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.htct.2020.11.010","article-title":"HemoTypeSC point\u2010of\u2010care testing shows high sensitivity with alkaline cellulose acetate haemoglobin electrophoresis for screening haemoglobin SS and SC genotypes","volume":"44","author":"Adegoke SA","year":"2022","journal-title":"Hematol Transfus Cell Ther"},{"issue":"7","key":"e_1_2_4_4_1","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1377\/hlthaff.2012.0255","article-title":"Replicating PEPFAR's success: how interventions shown to be effective abroad can be applied to the AIDS epidemic in the US","volume":"31","author":"Fu J","year":"2012","journal-title":"Health Aff (Millwood)"},{"issue":"3","key":"e_1_2_4_5_1","doi-asserted-by":"crossref","first-page":"e386","DOI":"10.1016\/S2214-109X(25)00455-3","article-title":"Low\u2010dose aspirin for preventing intrauterine growth restriction and pre\u2010eclampsia in sickle cell pregnancy in Nigeria (PIPSICKLE): a randomised controlled trial","volume":"14","author":"Afolabi BB","year":"2026","journal-title":"Lancet Glob Health"},{"issue":"6","key":"e_1_2_4_6_1","doi-asserted-by":"crossref","first-page":"e425","DOI":"10.1016\/S2352-3026(24)00078-4","article-title":"Hydroxyurea dose optimisation for children with sickle cell anaemia in Sub\u2010Saharan Africa (REACH): extended follow\u2010up of a multicentre, open\u2010label, phase 1\/2 trial","volume":"11","author":"Aygun B","year":"2024","journal-title":"Lancet Haematol"},{"key":"e_1_2_4_7_1","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.802355","article-title":"Establishing a sickle cell disease registry in Africa: experience from the sickle pan\u2010African research consortium, Kumasi\u2010Ghana","volume":"13","author":"Paintsil V","year":"2022","journal-title":"Front Genet"},{"key":"e_1_2_4_8_1","doi-asserted-by":"crossref","DOI":"10.1093\/database\/baag007","article-title":"The Sickle Africa Data Coordinating Centre (SADaCC): a data science hub for interdisciplinary sickle cell disease research and training","volume":"2026","author":"Wonkam A","year":"2026","journal-title":"Database (Oxford)"},{"key":"e_1_2_4_9_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103597","article-title":"Rituximab is associated with an increased risk of malaria among adult lymphoma patients in Malawi: a prospective observational cohort","volume":"90","author":"Eastburg L","year":"2025","journal-title":"EClinicalMedicine"},{"issue":"2","key":"e_1_2_4_10_1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1056\/NEJMoa1813598","article-title":"Hydroxyurea for children with sickle cell Anaemia in Sub\u2010Saharan Africa","volume":"380","author":"Tshilolo L","year":"2019","journal-title":"N Engl J Med"},{"issue":"26","key":"e_1_2_4_11_1","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1056\/NEJMoa2000146","article-title":"Hydroxyurea dose escalation for sickle cell Anaemia in Sub\u2010Saharan Africa","volume":"382","author":"John CC","year":"2020","journal-title":"N Engl J Med"},{"key":"e_1_2_4_12_1","article-title":"Daily zinc supplementation for infection prevention in children with sickle cell Anaemia: the ZIPS\u20102 randomized clinical trial","author":"Namazzi R","year":"2026","journal-title":"JAMA"},{"issue":"5","key":"e_1_2_4_13_1","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2352-3026(21)00059-4","article-title":"Voxelotor in adolescents and adults with sickle cell disease (HOPE): long\u2010term follow\u2010up results of an international, randomised, double\u2010blind, placebo\u2010controlled, phase 3 trial","volume":"8","author":"Howard J","year":"2021","journal-title":"Lancet Haematol"},{"key":"e_1_2_4_14_1","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1002\/ajh.70466","article-title":"Subphenotypes of sickle cell disease: a guide to targeting treatment?","volume":"101","author":"Steinberg MH","year":"2026","journal-title":"Am J Hematol"},{"key":"e_1_2_4_15_1","unstructured":"Pfizer.Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology.2022."}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.70857","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bjh.70857","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.70857","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T03:06:56Z","timestamp":1790564816000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.70857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,27]]},"references-count":14,"alternative-id":["10.1111\/bjh.70857"],"URL":"https:\/\/doi.org\/10.1111\/bjh.70857","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,27]]},"assertion":[{"value":"2026-09-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"bjh.70857"}}